Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedOct 21, 2015P-P-P (COBAL) 30-1-20/mLLack of assurance of sterilityBedford Pharmacy · D-0041-2016Class IITerminatedOct 21, 2015MethylcobalaminLack of assurance of sterilityBedford Pharmacy · D-0040-2016Class IIITerminatedOct 21, 2015Meijer Loratadine Orally Disintegrating TabletsSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0039-2016Class IIITerminatedOct 21, 2015Wal-itin Loratadine Orally Disintegrating TabletsSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0038-2016Class IIITerminatedOct 21, 2015Sunmark loratadine Orally Disintegrating TabletsSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0037-2016Class IIITerminatedOct 21, 2015Up&Up loratadine orally disintegrating tabletsSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0036-2016Class IIITerminatedOct 21, 2015TopCare LORATIDINE ORALLY DISINTEGRATING TABLETSSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0035-2016Class IIITerminatedOct 21, 2015Safeway Care Loratadine Orally Disintegrating TabletsSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0034-2016Class IIITerminatedOct 21, 2015Premier Value Loratadine Orally Disintegrating TabletsSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0033-2016Class IIITerminatedOct 21, 2015Ohm Loratadine Orally Disintegrating TabletsSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0032-2016Class IIITerminatedOct 21, 2015Major loratadine orally disintegrating tabletsSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0031-2016Class IIITerminatedOct 21, 2015Leader Loratadine Orally Disintegrating TabletsSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0030-2016Class IIITerminatedOct 21, 2015HEB Loratadine Orally Disintegrating TabletsSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0029-2016Class IIITerminatedOct 21, 2015Health Mart Pharmacy loratadine orally disintegrating tabletsSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0028-2016Class IIITerminatedOct 21, 2015Good Neighbor Pharmacy Loratadine Orally Disintegrating TabletsSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0027-2016Class IIITerminatedOct 21, 2015Fred's Loratadine Orally Disintegrating TabletsSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0026-2016Class IIITerminatedOct 21, 2015Equaline Original Prescription StrengthSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0025-2016Class IIITerminatedOct 21, 2015Discount Drug Mart Food FairSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0024-2016Class IIITerminatedOct 21, 2015CVS PharmacySuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0023-2016Class IIITerminatedOct 21, 2015CareOne Original Prescription StrengthSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0022-2016Class IIITerminatedOct 21, 2015Health Best Choice CareSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0021-2016Class IIITerminatedOct 21, 2015Rite Aid Pharmacy loratadine orally disintegrating tablets USPSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0020-2016Class IIITerminatedOct 21, 2015QC Quality Choice Loratadine Orally Disintegrating TabletsSuperpotent Drug: Out Of Specification (OOS) result for Assay.Ohm Laboratories, Inc. · D-0019-2016Class IITerminatedOct 21, 2015WellPatch¿ Capsaicin Pain Relief PatchLabeling: Incorrect Instructions; The word not is missing from the following sentences "do bandage tightly or cover with any type of wrap except clothing and "do use...The Mentholatum Co. · D-0018-2016Class IIITerminatedOct 21, 2015Fenofibric Acid Tablets 105 mgChemical Contamination: The product may contain trace amounts of benzophenone, a component of the label varnish that may leach through the bottle and into the drug...Tribute Pharmaceuticals US Inc. · D-0017-2016Class IIITerminatedOct 21, 2015Fenofibric Acid TabletsChemical Contamination: The product may contain trace amounts of benzophenone, a component of the label varnish that may leach through the bottle and into the drug...Tribute Pharmaceuticals US Inc. · D-0016-2016Class IIITerminatedOct 21, 2015Bravelle 75 IUSubpotent DrugFerring Pharmaceuticals Inc · D-0015-2016Class IITerminatedOct 21, 2015Metformin Hydrochloride Extended-Release TabletsFailed Dissolution Specifications: Low Out-of-Specification results for the 8 hour timepoint.Actavis Laboratories, FL, Inc. · D-0014-2016Class IITerminatedOct 21, 2015SedalmexCross Contamination With Other Products: Potential cross-contamination of cephalosporin.Midway Importing, Inc · D-0013-2016Class IIITerminatedOct 21, 2015FUROSEMIDE Tablets USPCGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled...Boehringer Ingelheim Roxane Inc · D-0012-2016Class IIITerminatedOct 21, 2015FUROSEMIDE Tablets USPCGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled...Boehringer Ingelheim Roxane Inc · D-0011-2016Class IITerminatedOct 21, 2015Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation SolutionLack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling processNephron Pharmaceuticals Corp. · D-0010-2016Class IITerminatedOct 21, 2015Bromfenac Ophthalmic Solution 0.09%Lack of Assurance of Sterility: Failed preservative effectiveness testingApotex Inc. · D-0009-2016Class IITerminatedOct 14, 2015DaytranaDefective Delivery System: Out of specification for z-statistic related to mechanical peel force.Noven Pharmaceuticals, Inc. · D-0008-2016Class IITerminatedOct 14, 2015VytorinPresence of Foreign Tablet/Capsule: Vytorin 10 mg/40 mg tablets were found in bottles of Vytorin 10 mg/20 mg tablets.Merck Sharp & Dohme, Wilson Facility · D-0007-2016Class IITerminatedOct 14, 2015Sermorelin 6mg/6mL Lyophilized PowderLack of Assurance of Sterility: A recent FDA inspection found that this product was not being compounded in an area appropriate for lyophilization which may lead to a...Diabetes Corporation of America dba DCA Pharmacy · D-0006-2016Class IIITerminatedOct 7, 2015Verapamil Hydrochloride Extended-Release tabletsFailed Dissolution Specification: One lot of product did not meet the first stage dissolution specification limits.Apotex Inc. · D1834-2015Class IITerminatedOct 7, 2015All Products Intended to be SterileLack of Assurance of SterilityMedistat RX L.L.C. · D-1833-2015Class IITerminatedOct 7, 2015LIPO B STERILE INJECTION 10 mLSubpotent Drug: trace amounts of methylcobalamin in compounded drug.Eagle Pharmacy, Inc. · D-1832-2015Class IIITerminatedOct 7, 2015METOCLOPRAMIDE ORAL SOLUTIONDefective Container: Lids on unit dose cups are not fully qualified.VistaPharm, Inc. · D-1831-2015